| Cat# | CAS-0901 |
| Source | E. coli |
| Description | Cas9 Nuclease cloned from wild-type Streptococcus pyogenes, enables gene modification of hematopoietic stem cells, T cells, etc. Codon optimized, NLS designed, optimized E. coli expression and purification produced via these steps. |
| Storage | Dry ice shipping, -20 ± 5℃ storage, avoid freeze-thaw |
| Purity | ≥95% (Bis-Tris PAGE/SEC-HPLC) |
| Buffer | 30 mM Tris-HCl, 300 mM NaCl, 0.1 mM EDTA, 50% Glycerol, pH 7.4 |
| Abbr | SpCas9 |
| Applications | Involved in cell and gene therapy drugs (HSC, T cells) Gene Modification. |
| Appearance | Liquid |
| Molecular Weight | 163 kDa |
| Species | Streptococcus pyogenes |
| Concentration | 10 mg/ml |
| Endotoxin Level | ≤10 EU/mg |
| Grade | Research Grade |
| Download Datasheet: |  |
